vs

Side-by-side financial comparison of BAR HARBOR BANKSHARES (BHB) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

BAR HARBOR BANKSHARES is the larger business by last-quarter revenue ($48.9M vs $37.2M, roughly 1.3× Organogenesis Holdings Inc.). On growth, BAR HARBOR BANKSHARES posted the faster year-over-year revenue change (27.3% vs -57.1%). Over the past eight quarters, BAR HARBOR BANKSHARES's revenue compounded faster (15.9% CAGR vs -46.5%).

Bar Harbor Bankshares is a U.S. regional bank holding company headquartered in Maine. It offers retail and commercial banking services including deposit products, personal and business loans, wealth management, and mortgage solutions, mainly serving customers across Maine, New Hampshire, and Vermont.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

BHB vs ORGO — Head-to-Head

Bigger by revenue
BHB
BHB
1.3× larger
BHB
$48.9M
$37.2M
ORGO
Growing faster (revenue YoY)
BHB
BHB
+84.3% gap
BHB
27.3%
-57.1%
ORGO
Faster 2-yr revenue CAGR
BHB
BHB
Annualised
BHB
15.9%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BHB
BHB
ORGO
ORGO
Revenue
$48.9M
$37.2M
Net Profit
$11.8M
Gross Margin
30.8%
Operating Margin
30.1%
-185.1%
Net Margin
24.0%
Revenue YoY
27.3%
-57.1%
Net Profit YoY
6.9%
EPS (diluted)
$0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BHB
BHB
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$48.9M
$225.6M
Q3 25
$47.5M
$150.9M
Q2 25
$34.5M
$101.0M
Q1 25
$37.9M
$86.7M
Q4 24
$38.5M
$126.7M
Q3 24
$38.6M
$115.2M
Q2 24
$37.2M
$130.2M
Net Profit
BHB
BHB
ORGO
ORGO
Q1 26
Q4 25
$11.8M
$43.7M
Q3 25
$8.9M
$21.6M
Q2 25
$6.1M
$-9.4M
Q1 25
$10.2M
$-18.8M
Q4 24
$11.0M
$7.7M
Q3 24
$12.2M
$12.3M
Q2 24
$10.3M
$-17.0M
Gross Margin
BHB
BHB
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
BHB
BHB
ORGO
ORGO
Q1 26
-185.1%
Q4 25
30.1%
28.1%
Q3 25
23.2%
13.7%
Q2 25
21.6%
-12.5%
Q1 25
33.5%
-30.9%
Q4 24
35.2%
8.1%
Q3 24
35.3%
5.4%
Q2 24
34.4%
-10.7%
Net Margin
BHB
BHB
ORGO
ORGO
Q1 26
Q4 25
24.0%
19.4%
Q3 25
18.6%
14.3%
Q2 25
17.6%
-9.3%
Q1 25
26.9%
-21.7%
Q4 24
28.6%
6.1%
Q3 24
31.6%
10.7%
Q2 24
27.6%
-13.1%
EPS (diluted)
BHB
BHB
ORGO
ORGO
Q1 26
Q4 25
$0.71
$0.31
Q3 25
$0.54
$0.11
Q2 25
$0.40
$-0.10
Q1 25
$0.66
$-0.17
Q4 24
$0.71
$0.05
Q3 24
$0.80
$0.09
Q2 24
$0.67
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BHB
BHB
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$80.8M
$91.4M
Total DebtLower is stronger
$134.8M
Stockholders' EquityBook value
$532.5M
Total Assets
$4.7B
$520.0M
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BHB
BHB
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$80.8M
$93.7M
Q3 25
$136.7M
$63.7M
Q2 25
$87.0M
$73.1M
Q1 25
$88.1M
$110.0M
Q4 24
$72.2M
$135.6M
Q3 24
$81.2M
$94.3M
Q2 24
$101.8M
$89.9M
Total Debt
BHB
BHB
ORGO
ORGO
Q1 26
Q4 25
$134.8M
Q3 25
$134.6M
Q2 25
$40.9M
Q1 25
$40.9M
Q4 24
$40.9M
Q3 24
$60.9M
$62.3M
Q2 24
$60.8M
$63.8M
Stockholders' Equity
BHB
BHB
ORGO
ORGO
Q1 26
Q4 25
$532.5M
$300.1M
Q3 25
$521.0M
$255.1M
Q2 25
$468.9M
$233.2M
Q1 25
$467.3M
$242.9M
Q4 24
$458.4M
$262.9M
Q3 24
$459.9M
$278.5M
Q2 24
$438.9M
$263.5M
Total Assets
BHB
BHB
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$4.7B
$598.7M
Q3 25
$4.7B
$509.8M
Q2 25
$4.1B
$461.1M
Q1 25
$4.1B
$467.4M
Q4 24
$4.1B
$497.9M
Q3 24
$4.0B
$446.3M
Q2 24
$4.0B
$443.2M
Debt / Equity
BHB
BHB
ORGO
ORGO
Q1 26
Q4 25
0.25×
Q3 25
0.26×
Q2 25
0.09×
Q1 25
0.09×
Q4 24
0.09×
Q3 24
0.13×
0.22×
Q2 24
0.14×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BHB
BHB
ORGO
ORGO
Operating Cash FlowLast quarter
$48.3M
Free Cash FlowOCF − Capex
$43.5M
FCF MarginFCF / Revenue
88.8%
Capex IntensityCapex / Revenue
9.8%
Cash ConversionOCF / Net Profit
4.10×
TTM Free Cash FlowTrailing 4 quarters
$70.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BHB
BHB
ORGO
ORGO
Q1 26
Q4 25
$48.3M
$39.4M
Q3 25
$16.5M
$3.1M
Q2 25
$5.3M
$-32.9M
Q1 25
$9.3M
$-19.9M
Q4 24
$52.4M
$10.9M
Q3 24
$23.5M
$8.7M
Q2 24
$7.1M
$4.7M
Free Cash Flow
BHB
BHB
ORGO
ORGO
Q1 26
Q4 25
$43.5M
$34.8M
Q3 25
$15.4M
$844.0K
Q2 25
$3.3M
$-36.5M
Q1 25
$7.8M
$-23.6M
Q4 24
$45.0M
$7.6M
Q3 24
$22.4M
$6.1M
Q2 24
$2.3M
$2.9M
FCF Margin
BHB
BHB
ORGO
ORGO
Q1 26
Q4 25
88.8%
15.4%
Q3 25
32.5%
0.6%
Q2 25
9.5%
-36.1%
Q1 25
20.5%
-27.2%
Q4 24
116.9%
6.0%
Q3 24
58.1%
5.3%
Q2 24
6.1%
2.2%
Capex Intensity
BHB
BHB
ORGO
ORGO
Q1 26
Q4 25
9.8%
2.1%
Q3 25
2.3%
1.5%
Q2 25
5.8%
3.6%
Q1 25
4.1%
4.2%
Q4 24
19.2%
2.7%
Q3 24
2.7%
2.2%
Q2 24
12.9%
1.4%
Cash Conversion
BHB
BHB
ORGO
ORGO
Q1 26
Q4 25
4.10×
0.90×
Q3 25
1.87×
0.14×
Q2 25
0.86×
Q1 25
0.91×
Q4 24
4.76×
1.43×
Q3 24
1.93×
0.71×
Q2 24
0.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons